Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a vaccine therapy for patients with stage IV melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED